The biomarker discovery outsourcing service market is estimated to be valued at USD 13.3 billion in 2024. The biomarker discovery outsourcing service market is predicted to rise at a CAGR of 12.2% from 2024 to 2034. The global biomarker discovery outsourcing service market is anticipated to reach USD 41.4 billion by 2034.
| Attributes | Key Insights |
|---|---|
| Estimated Market Size in 2024 | USD 13.3 billion |
| Projected Market Value in 2034 | USD 41.4 billion |
| Value-based CAGR from 2024 to 2034 | 12.2% |
The increasing research and development activities in the biotechnology and pharmaceutical industries are expected to drive the biomarker discovery outsourcing service market. Outsourcing services are in demand as demand for biomarkers is increasing in the diagnosis and treatment monitoring of various diseases.
With the increasing burden of various chronic diseases such as cancer, neurological disorders, and cardiovascular disorders, the demand for various biomarkers has increased significantly.
From 2019 to 2023, the biomarker discovery outsourcing service market experienced a CAGR of 15.6%. Increasing advances in technology like bioinformatics, genomics and proteomics, the demand for biomarker discovery outsourcing service are expected to rise.
The biomarkers are primarily utilised in drug development and clinical research applications, the market for outsourcing services is expected to rise. The rising integration of biomarkers in precision medicine drive the demand for outsourcing services tailored to personalized treatment strategies.
The biomarker discovery outsourcing service market is poised for continued expansion with Incresed technological advances and expansion in new therapeutic area. Projections indicate that the global biomarker discovery outsourcing service market will experience a CAGR of 12.2% from 2024 to 2034.
| Historical CAGR from 2019 to 2023 | 15.6% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 12.2% |
The provided table highlights the top five countries in terms of revenue, with the South Korea and Japan leading the list. Incresed regulatory support and funding in biopharmaceutical in South Korea boost the market growth. Biomarker discovery outsourcing service market in Japan is mainly driven by advances in healthcare industry.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 12.4% |
| The United Kingdom | 13.3% |
| China | 12.9% |
| Japan | 13.9% |
| South Korea | 14.0% |
The biomarker discovery outsourcing service market in the United States is expected to expand with a CAGR of 12.4% from 2024 to 2034. Increasing investment in research and development in biopharmaceutical industry driving the market growth.
With the increasing demand for personalized medicines and innovative healthcare solutions, the demand for biomarker discovery outsourcing service is expected to rise in the country.
The increasing advanced in next generation sequencing and bioinformatics accelerated biomarker discovery, providing opportunities for outsourcing services to provide cutting edge solutions to their clients.
The biomarker discovery outsourcing service market in the United Kingdom is expected to expand with a CAGR of 13.3% from 2024 to 2034. The growth of the market in the country is attributed to the presence of robust biotechnology industry.
Increasing government support and funding for biomedical research initiatives drive the demand for outsourcing services. The presence of advanced healthcare infrastructure and increased access to cutting edge technology to boost the market for biomarker discovery outsourcing service in the United Kingdom.
The biomarker discovery outsourcing service market in China is expected to expand with a CAGR of 12.9% from 2024 to 2034. The increasing focus on precision medicines in China contributed to the market growth.
The presence to large patient population and availability of diverse genetic data enhances the quality and relevance of biomarker discovery services in China.
With increasing healthcare innovation and growing demand for customized medicines is increasing, the biomarker discovery outsourcing service market in china will continue to rise during the forecast period.
The biomarker discovery outsourcing service market in Japan is expected to expand with a CAGR of 13.9% from 2024 to 2034.
With the presence of advanced healthcare infrastructure and strong biotechnology sector in Japan, the demand for biomarker discovery outsourcing services for drug discovery and development are expected to rise in the country.
The growing aging population and increased healthcare challenges and various age related disorders such as neurological diseases, cardiovascular disorders, driving the market demand.
Increasing government support and investment in biopharmaceutical industry and Incresed research and development activity are expected to drive the marker discovery outsourcing service market in South Korea.
With the increasing demand for innovative healthcare solutions and precision medicine in South Korea the market for biomarker discovery outsourcing services is expected to rise in the country.
The biomarker discovery outsourcing service market in South Korea is expected to expand with a CAGR of 14% from 2024 to 2034.
The below segment shows the leading segment. Surrogate end-point segment is to rise at a CAGR of 12.0% from 2024 to 2034.Based on type, the genomic biomarker services segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 11.8% from 2024 to 2034.
| Category | CAGR from 2024 to 2034 |
|---|---|
| Surrogate End-point | 12.0% |
| Genomic Biomarker Services | 11.8% |
Based on the type, the biomarker discovery outsourcing service market is segmented into predictive biomarkers, prognostic biomarkers, safety biomarkers, surrogate endpoints and other types.
Among these types surrogate end-point segment is anticipated to rise at a CAGR of 12.0% from 2024 to 2034. The demand for surrogate endpoint is high as they provide shorter and cost effective trials.
Surrogate endpoints open up new possibilities for innovation in therapeutic development, as they make it possible to access new treatment more quickly.
Based on the service, the biomarker discovery outsourcing service market is segmented into genomic biomarker services, proteomics biomarker services, bioinformatics biomarker services and other biomarker services. Among these services, genomic biomarker services segment is anticipated to thrive at a CAGR of 11.8 % from 2024 to 2034
Genomic biomarkers are used in early diagnostic and tracking of genetic diseases, infectious diseases and inherited disorders. The increasing reliance on precision medicines driving the high demand for genomic biomarker services.
The market players operation in biomarker discovery outsourcing service market are concentrating on partnership, collaboration, acquisition to gain competitive edge in the market. The leading players are investing in research and development and expansion of service offerings.
Market players are increasing range of service to provide comprehensive biomarker services catering to unique demand of various biotechnology and pharmaceutical clients.
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | USD 13.3 billion |
| Projected Market Valuation in 2034 | USD 41.4 billion |
| Value-based CAGR 2024 to 2034 | 12.2% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD billion |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa |
| Key Market Segments Covered | Type, Service, Therapeutic Area, End User, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | Bio-Rad Laboratories, Inc.; Parexel International (MA) Corporation; Svar Life Science; Sino Biological Inc.; ICON plc.; Integrated DNA Technologies Inc.; Almac Group Limited; REPROCELL Inc.; Frontage Labs; Biomcare ApS; Crown Bioscience |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 10: North America Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 13: Latin America Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 14: Latin America Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 15: Latin America Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 17: Western Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 18: Western Europe Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 20: Western Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 21: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: Eastern Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 23: Eastern Europe Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 24: Eastern Europe Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 26: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 27: South Asia and Pacific Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 28: South Asia and Pacific Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 29: South Asia and Pacific Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 30: South Asia and Pacific Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 31: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: East Asia Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 33: East Asia Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 34: East Asia Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 35: East Asia Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Table 36: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 37: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2019 to 2034
Table 38: Middle East and Africa Market Value (US$ Million) Forecast by Service, 2019 to 2034
Table 39: Middle East and Africa Market Value (US$ Million) Forecast by Therapeutic Area, 2019 to 2034
Table 40: Middle East and Africa Market Value (US$ Million) Forecast by End-User, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Service, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by End-User, 2024 to 2034
Figure 5: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 12: Global Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 13: Global Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 14: Global Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 15: Global Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 16: Global Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 17: Global Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 18: Global Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 21: Global Market Attractiveness by Type, 2024 to 2034
Figure 22: Global Market Attractiveness by Service, 2024 to 2034
Figure 23: Global Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 24: Global Market Attractiveness by End-User, 2024 to 2034
Figure 25: Global Market Attractiveness by Region, 2024 to 2034
Figure 26: North America Market Value (US$ Million) by Type, 2024 to 2034
Figure 27: North America Market Value (US$ Million) by Service, 2024 to 2034
Figure 28: North America Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 29: North America Market Value (US$ Million) by End-User, 2024 to 2034
Figure 30: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 38: North America Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 39: North America Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 40: North America Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 41: North America Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 42: North America Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 43: North America Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 44: North America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 45: North America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 46: North America Market Attractiveness by Type, 2024 to 2034
Figure 47: North America Market Attractiveness by Service, 2024 to 2034
Figure 48: North America Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 49: North America Market Attractiveness by End-User, 2024 to 2034
Figure 50: North America Market Attractiveness by Country, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) by Type, 2024 to 2034
Figure 52: Latin America Market Value (US$ Million) by Service, 2024 to 2034
Figure 53: Latin America Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) by End-User, 2024 to 2034
Figure 55: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 59: Latin America Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 62: Latin America Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 68: Latin America Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 71: Latin America Market Attractiveness by Type, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Service, 2024 to 2034
Figure 73: Latin America Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 74: Latin America Market Attractiveness by End-User, 2024 to 2034
Figure 75: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Million) by Type, 2024 to 2034
Figure 77: Western Europe Market Value (US$ Million) by Service, 2024 to 2034
Figure 78: Western Europe Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 79: Western Europe Market Value (US$ Million) by End-User, 2024 to 2034
Figure 80: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 84: Western Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 87: Western Europe Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 90: Western Europe Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 93: Western Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 94: Western Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Type, 2024 to 2034
Figure 97: Western Europe Market Attractiveness by Service, 2024 to 2034
Figure 98: Western Europe Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 99: Western Europe Market Attractiveness by End-User, 2024 to 2034
Figure 100: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Million) by Type, 2024 to 2034
Figure 102: Eastern Europe Market Value (US$ Million) by Service, 2024 to 2034
Figure 103: Eastern Europe Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 104: Eastern Europe Market Value (US$ Million) by End-User, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 106: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 112: Eastern Europe Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 115: Eastern Europe Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 118: Eastern Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 121: Eastern Europe Market Attractiveness by Type, 2024 to 2034
Figure 122: Eastern Europe Market Attractiveness by Service, 2024 to 2034
Figure 123: Eastern Europe Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 124: Eastern Europe Market Attractiveness by End-User, 2024 to 2034
Figure 125: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 126: South Asia and Pacific Market Value (US$ Million) by Type, 2024 to 2034
Figure 127: South Asia and Pacific Market Value (US$ Million) by Service, 2024 to 2034
Figure 128: South Asia and Pacific Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ Million) by End-User, 2024 to 2034
Figure 130: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 131: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 132: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 133: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 134: South Asia and Pacific Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 138: South Asia and Pacific Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 139: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 140: South Asia and Pacific Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 141: South Asia and Pacific Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 142: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 143: South Asia and Pacific Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 144: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 145: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 146: South Asia and Pacific Market Attractiveness by Type, 2024 to 2034
Figure 147: South Asia and Pacific Market Attractiveness by Service, 2024 to 2034
Figure 148: South Asia and Pacific Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 149: South Asia and Pacific Market Attractiveness by End-User, 2024 to 2034
Figure 150: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 151: East Asia Market Value (US$ Million) by Type, 2024 to 2034
Figure 152: East Asia Market Value (US$ Million) by Service, 2024 to 2034
Figure 153: East Asia Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 154: East Asia Market Value (US$ Million) by End-User, 2024 to 2034
Figure 155: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 156: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 157: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 158: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 159: East Asia Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 160: East Asia Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 161: East Asia Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 162: East Asia Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 165: East Asia Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 166: East Asia Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 167: East Asia Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 168: East Asia Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 169: East Asia Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 170: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 171: East Asia Market Attractiveness by Type, 2024 to 2034
Figure 172: East Asia Market Attractiveness by Service, 2024 to 2034
Figure 173: East Asia Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 174: East Asia Market Attractiveness by End-User, 2024 to 2034
Figure 175: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Value (US$ Million) by Type, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ Million) by Service, 2024 to 2034
Figure 178: Middle East and Africa Market Value (US$ Million) by Therapeutic Area, 2024 to 2034
Figure 179: Middle East and Africa Market Value (US$ Million) by End-User, 2024 to 2034
Figure 180: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 182: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 183: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 184: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2019 to 2034
Figure 185: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2024 to 2034
Figure 186: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034
Figure 187: Middle East and Africa Market Value (US$ Million) Analysis by Service, 2019 to 2034
Figure 188: Middle East and Africa Market Value Share (%) and BPS Analysis by Service, 2024 to 2034
Figure 189: Middle East and Africa Market Y-o-Y Growth (%) Projections by Service, 2024 to 2034
Figure 190: Middle East and Africa Market Value (US$ Million) Analysis by Therapeutic Area, 2019 to 2034
Figure 191: Middle East and Africa Market Value Share (%) and BPS Analysis by Therapeutic Area, 2024 to 2034
Figure 192: Middle East and Africa Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2024 to 2034
Figure 193: Middle East and Africa Market Value (US$ Million) Analysis by End-User, 2019 to 2034
Figure 194: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034
Figure 195: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034
Figure 196: Middle East and Africa Market Attractiveness by Type, 2024 to 2034
Figure 197: Middle East and Africa Market Attractiveness by Service, 2024 to 2034
Figure 198: Middle East and Africa Market Attractiveness by Therapeutic Area, 2024 to 2034
Figure 199: Middle East and Africa Market Attractiveness by End-User, 2024 to 2034
Figure 200: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
As of 2024, the market for biomarker discovery outsourcing service is expected to be valued at USD 13.3 billion.
By 2034, the market value of biomarker discovery outsourcing service is expected to reach USD 41.4 billion.
From 2024 to 2034, the biomarker discovery outsourcing service market is expected to flourish at a CAGR of 12.2%
Surrogate end-point segment is expected to rise at a CAGR of 12% from 2024 to 2034.
South Korea is likely the top-performing market, with a CAGR of 14%.
Explore Similar Insights
Biomarker Discovery Outsourcing Service Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
